CRNX - Crinetics Pharmaceuticals, Inc. -  [ ]

Ticker Details
Crinetics Pharmaceuticals, Inc.
IPO Date: July 16, 2018
Sector: Healthcare
Industry: Biotech
Market Cap: $8.88B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.75 | 2.83%
Avg Daily Range (30 D): $2.02 | 4.99%
Avg Daily Range (90 D): $1.30 | 3.34%
Institutional Daily Volume
Avg Daily Volume: .47M
Avg Daily Volume (30 D): 5.03M
Avg Daily Volume (90 D): 2.36M
Trade Size
Avg Trade Size (Sh.): 69
Avg Trade Size (Sh.) (30 D): 189
Avg Trade Size (Sh.) (90 D): 115
Institutional Trades
Total Institutional Trades: 3,761
Avg Institutional Trade: $3.73M
Avg Institutional Trade (30 D): $7.22M
Avg Institutional Trade (90 D): $6.32M
Avg Institutional Trade Volume: .08M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $5.05M
Avg Closing Trade (30 D): $23.03M
Avg Closing Trade (90 D): $11.86M
Avg Closing Volume: 133.53K
 
News
Jul 15, 2026 @ 4:42 PM
Halper Sadeh LLC is Investigating Whether ESI, CRN...
Source: Halper Sadeh Llc
Jul 13, 2026 @ 6:27 PM
Does Vertex's Acquisition of Crinetics Pharmaceuti...
Source: David Jagielski, Cpa
Jul 10, 2026 @ 7:02 PM
Why This Pharmaceutical Stock Jumped Close to 100%...
Source: Brett Schafer
Jul 10, 2026 @ 8:05 AM
Vertex Pharmaceuticals Just Made a $10 Billion Mov...
Source: Adria Cimino
Jul 8, 2026 @ 6:35 PM
Halper Sadeh LLC is Investigating Whether CRNX, ES...
Source: Halper Sadeh Llc
Financials
  TTM Q4 2025 FY 2025
Basic EPS $-1.23 $-1.29 $-4.95
Diluted EPS $-1.23 $-1.29 $-4.95
Revenue $10.73M $6.16M $7.7M
Gross Profit $10.53M $6.62M
Net Income / Loss $-127.85M $-122.82M $-465.32M
Operating Income / Loss $-140.38M $-133.67M $-516.77M
Cost of Revenue $.2M $1.08M
Net Cash Flow $12.81M $-9.76M $-163.4M
PE Ratio